Semaglutide: How It Works, What It's Studied For & Safety
Semaglutide is a GLP-1 receptor agonist FDA-approved for type 2 diabetes (Ozempic, Rybelsus) and chronic weight management (Wegovy). Clinicians consider it for glycemic control in type 2 diabetes (FDA-approved). Branded products are FDA-approved under labeled indications; compounded variants are dispensed by Wells Pharmacy Network only after a licensed clinician evaluates intake, history, and labs.
Also known as: Ozempic, Wegovy, Rybelsus
How does Semaglutide work?
Semaglutide mimics endogenous GLP-1, a gut hormone released after meals. It binds the GLP-1 receptor on pancreatic beta cells (enhancing glucose-dependent insulin secretion), neurons in appetite-regulating regions (reducing food intake), and the gastric wall (slowing gastric emptying).
What is Semaglutide studied for?
- Glycemic control in type 2 diabetes (FDA-approved)
- Chronic weight management in adults with obesity or overweight with comorbidities (FDA-approved)
- Cardiovascular risk reduction in adults with established cardiovascular disease (FDA-approved expansion)
How is Semaglutide taken?
FDA-approved as a once-weekly subcutaneous injection (Ozempic, Wegovy) and a daily oral tablet (Rybelsus). Compounded preparations on this site are not FDA-approved and are not generic equivalents of any branded product.
Is Semaglutide FDA-approved? Is it safe?
FDA-approved as a finished drug product when prescribed under its labeled indications. Compounded variants on this site are separate from the branded product and are dispensed only when a clinician determines a compounded preparation is appropriate. GI side effects (nausea, vomiting, constipation) are common, especially during dose escalation. Boxed warning for thyroid C-cell tumors in rodents. Compounded prescription-only preparations are dispensed by Wells Pharmacy Network. Eligibility is decided by a licensed clinician based on intake and labs, not by checkout. Compounded products on this site are not FDA-approved and are not generic equivalents of any branded medication.
In the Regen Therapy catalog
This compound does not currently appear in an active Regen Therapy protocol. Browse the full catalog for adjacent options.
What does the research say about Semaglutide?
STEP and SUSTAIN trial programs supported the obesity and diabetes approvals; SELECT supported the cardiovascular risk-reduction expansion.
Citations & further reading
Considering Semaglutide as part of a protocol?
Browse Regen Therapy's catalog or start a clinician evaluation. Every prescription is reviewed by a licensed clinician and dispensed by Wells Pharmacy Network.
Browse the catalog →